EFFECT ON NONSPECIFIC IMMUNOLOGICAL PARAMETERS IN THE USE OF PROBIOTICS AND ANTIBIOTICS AGAINST COLIBACTERIOSIS OF LAMBS
DOI:
https://doi.org/10.55640/Keywords:
Lambs, colibacteriosis, Escherichia coli, probiotics, Maxlac/DW, innoprovet, enrofloxacin, nonspecific immune parameters, phagocytosis index (PhI), bactericidal activity (BASK), lysozyme activity, the complement system (CH50).Abstract
The aim of the study was to compare the effect of probiotics (Maxlac/DW, innoprovet) and antibiotics (enrofloxacin) used for the prevention and treatment of colibacteriosis in lambs on non—specific immune parameters (phagocytic index, bactericidal activity, lysozyme activity, complement system-CH50) in preventive and therapeutic conditions.it consists of a definition.b research — to compare the effect of probiotics (Maxlac/DW innoprovet) and antibiotics (enrofloxacin) used for the prevention and treatment of colibacteriosis in lambs on non-specific immune parameters (phagocytic index, bactericidal activity, lysozyme activity, complement system-CH50) in preventive and therapeutic conditions.it consists of a definition. In an experimental study, probiotics were injected into water/milk for 14 days in both preventive and curative regimens; while enrofloxacin was administered for 3-5 days of oral treatment; The groups were organized according to control and combined schemes. Phagocytosis, bactericidal activity, dynamics of lysozyme and CH50 were measured and statistically analyzed in blood samples for 1-28 days. The results showed that with the prophylactic use of the drug " Maxlac/ DV", the indicators of nonspecific immunity increased significantly: phagocytosis was ~50%, bactericidal activity ~64%, lysozyme ~ 34-35%, and the level of CH50 reached ~121-122 units; in infected control animals, these indicators decreased sharply. For therapeutic purposes, the combination of enrofloxacin and probiotics proved to be the most effective, restoring immunity and promoting clinical recovery; Probiotics have demonstrated superiority in immunostimulation when probiotics or antibiotics are used separately.
Downloads
References
1.Belkaid Y.; Hand T.W. Role of the microbiota in immunity and inflammation // Cell. — 2014. — Vol. 157, No. 1. — P. 121–141.
2.Gensollen T.; Iyer S.S.; Kasper D.L.; Blumberg R.S. How colonization by the microbiota in early life shapes the immune system // Science. — 2016. — Vol. 352. — P. 539–544.
3.Hooper L.V.; Littman D.R.; Macpherson A.J. Interactions between the microbiota and the immune system // Science. — 2012. — Vol. 336. — P. 1268–1273.
4.Jami E.; Mizrahi I. Composition and similarity of bovine rumen microbiota across individual animals // Journal of Animal Science. — 2012. — Vol. 90 (Suppl. 1). — P. 1–3.
5.Mackie R.I.; Sghir A.; Gaskins H.R. Developmental microbial ecology of the neonatal gastrointestinal tract // American Journal of Clinical Nutrition. — 1999. — Vol. 69 (Suppl.). — P. 1035S–1045S.
6.Martínez-Vazquez A.V.,. Rivera-Sanchez G, Lira-Mendez K., Reyes-Lopez M.A., Bocanegra-García V., Prevalence, antimicrobial resistance and virulence genes of Escherichia coli isolated from retail meat in Tamaulipas, Mexico, J. Glob. Antimicrob. Resist. 14 (2018) 266–272.
7.Round J.L.; Mazmanian S.K. The gut microbiota shapes intestinal immune responses // Nature Reviews Immunology. — 2009. — Vol. 9. — P. 313–323.
8.Xie W.Y.,. Shen Q, Zhao F.J., Antibiotics and antibiotic resistance from animal manures to soil: a review, Eur. J. Soil Sci. 69 (1) (2018) 181–195.
9.Латышев С.Н., Кононов А.Н. Влияние некоторых факторов риска при возникновении желудочно-кишечных заболеваний ягнят // Актуалные проблемы ветеринарного акушерства, гинекологии и биотехники размножения животных. Материалы международной научно-практической конференции. - Ставропол, 2007. -С. 93-95.
10.Латышев С.Н., Кононов А.Н. Определение роли Е.соlі в этиологии желудочно-кишечных болезней ягнят // Овцы, козы, шерстяное дело. Ставропол, 2008. -№3. -С. 76-79.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India